Andriulli A, Bergia R, Masoero G, Baiardi P, Pellegrino S, Tondolo M
Gastroenterology. 1979 Jul;77(1):86-90.
In order to assess to what extent glomerular or tubular function is involved in the renal handling of amylase and the lysozyme to creatine clearance ratios (CAm/CCr and CLys/CCr) were evaluated in 22 healthy volunteers and in 71 patients with different renal diseases. In normal controls, the mean CAm/CCr was 2.55 +/-1.54 SD, with an upper normal limit of 5.56. A normal ratio was found in patients with glomerulonephritis, with or without a nephrotic syndrome, and in patients with pyelonephritis. A significantly elevated ratio (P less than 0.001) was instead found in patients with uremia and in patients with uremia and in patients with either chronic or acute tubular damage. The CLus/CCr ratio was elevated in all the groups, except in patients with glomerulonephritis and minimal proteinuria. These results show that in humans, as in animals, the amylase filtered load undergoes partial tubular reabsorption. In renal diseases, an increase of the CAm/CCr is caused by either a marked reduction of functioning nephrons or a severe tubular damage, while the glomerular permeability does not seem to be involved. Some other mechanism is probably involved in the elevation of the CAm/CCr during acute pancreatitis.
为了评估肾小球或肾小管功能在肾脏处理淀粉酶过程中所起的作用,我们对22名健康志愿者和71名患有不同肾脏疾病的患者的淀粉酶与肌酐清除率比值(CAm/CCr)和溶菌酶与肌酐清除率比值(CLys/CCr)进行了评估。在正常对照组中,平均CAm/CCr为2.55±1.54标准差,正常上限为5.56。在患有肾小球肾炎(无论有无肾病综合征)的患者以及肾盂肾炎患者中发现比值正常。相反,在尿毒症患者以及患有慢性或急性肾小管损伤的患者中发现比值显著升高(P<0.001)。除了患有肾小球肾炎和微量蛋白尿的患者外,所有组的CLus/CCr比值均升高。这些结果表明,在人类和动物中一样,淀粉酶滤过量会经历部分肾小管重吸收。在肾脏疾病中,CAm/CCr升高是由功能性肾单位的显著减少或严重的肾小管损伤引起的,而肾小球通透性似乎并未参与其中。在急性胰腺炎期间,CAm/CCr升高可能涉及其他一些机制。